{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T02:49:48Z","timestamp":1784429388938,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200460"],"award-info":[{"award-number":["82200460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300071"],"award-info":[{"award-number":["82300071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20210030"],"award-info":[{"award-number":["BK20210030"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M711665"],"award-info":[{"award-number":["2022M711665"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Innovative and Entrepreneurial Talent Program","award":["JSSCBS20211539"],"award-info":[{"award-number":["JSSCBS20211539"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03647-w","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:31:01Z","timestamp":1774870261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CircATXN2 exacerbates pulmonary arterial hypertension by modulating the miR-138-5p\/SMURF1 axis"],"prefix":"10.1186","volume":"27","author":[{"given":"Zhiyuan","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"issue":"25","key":"3647_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMra2000348","volume":"385","author":"PM Hassoun","year":"2021","unstructured":"Hassoun PM. Pulmonary Arterial Hypertension. N Engl J Med. 2021;385(25):2361\u201376. https:\/\/doi.org\/10.1056\/NEJMra2000348.","journal-title":"N Engl J Med"},{"issue":"2","key":"3647_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41569-024-01064-4","volume":"22","author":"HA Ghofrani","year":"2025","unstructured":"Ghofrani HA, Gomberg-Maitland M, Zhao L, Grimminger F. Mechanisms and treatment of pulmonary arterial hypertension. Nat Rev Cardiol. 2025;22(2):105\u201320. https:\/\/doi.org\/10.1038\/s41569-024-01064-4.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"3647_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1164\/rccm.202302-0327SO","volume":"208","author":"S Johnson","year":"2023","unstructured":"Johnson S, Sommer N, Cox-Flaherty K, Weissmann N, Ventetuolo CE, Maron BA. Pulmonary Hypertension: A contemporary review. Am J Respir Crit Care Med. 2023;208(5):528\u201348. https:\/\/doi.org\/10.1164\/rccm.202302-0327SO.","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"3647_CR4","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1161\/CIRCULATIONAHA.112.107821","volume":"125","author":"CE Sparacino-Watkins","year":"2012","unstructured":"Sparacino-Watkins CE, Lai YC, Gladwin MT. Nitrate-nitrite-nitric oxide pathway in pulmonary arterial hypertension therapeutics. Circulation. 2012;125(23):2824\u20136. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.107821.","journal-title":"Circulation"},{"issue":"14","key":"3647_CR5","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.2022.4402","volume":"327","author":"NF Ruopp","year":"2022","unstructured":"Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review. JAMA. 2022;327(14):1379\u201391. https:\/\/doi.org\/10.1001\/jama.2022.4402.","journal-title":"JAMA"},{"issue":"38","key":"3647_CR6","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618\u2013731. https:\/\/doi.org\/10.1093\/eurheartj\/ehac237.","journal-title":"Eur Heart J"},{"key":"3647_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5492","volume":"360","author":"T Thenappan","year":"2018","unstructured":"Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:j5492. https:\/\/doi.org\/10.1136\/bmj.j5492.","journal-title":"BMJ"},{"issue":"10","key":"3647_CR8","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1164\/rccm.202401-0089PP","volume":"209","author":"RT Zamanian","year":"2024","unstructured":"Zamanian RT, Weatherald J, Sweatt AJ, et al. Constructing the framework for disease modification in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2024;209(10):1189\u201395. https:\/\/doi.org\/10.1164\/rccm.202401-0089PP.","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"3647_CR9","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","volume":"388","author":"MM Hoeper","year":"2023","unstructured":"Hoeper MM, Badesch DB, Ghofrani HA, et al. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16):1478\u201390. https:\/\/doi.org\/10.1056\/NEJMoa2213558.","journal-title":"N Engl J Med"},{"issue":"10","key":"3647_CR10","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.112.000765","volume":"127","author":"MM Hoeper","year":"2013","unstructured":"Hoeper MM, Barst RJ, Bourge RC, et al. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation. 2013;127(10):1128\u201338. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.000765.","journal-title":"Circulation"},{"issue":"11","key":"3647_CR11","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1073\/pnas.73.11.3852","volume":"73","author":"HL Sanger","year":"1976","unstructured":"Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73(11):3852\u20136. https:\/\/doi.org\/10.1073\/pnas.73.11.3852.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3647_CR12","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","volume":"185","author":"CX Liu","year":"2022","unstructured":"Liu CX, Chen LL. Circular RNAs: characterization, cellular roles, and applications. Cell. 2022;185(12):2016\u201334. https:\/\/doi.org\/10.1016\/j.cell.2022.04.021.","journal-title":"Cell"},{"issue":"12","key":"3647_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121755","volume":"11","author":"L Caba","year":"2021","unstructured":"Caba L, Florea L, Gug C, Dimitriu DC, Gorduza EV. Circular RNA-is the circle perfect? Biomolecules. 2021;11(12):1755. https:\/\/doi.org\/10.3390\/biom11121755.","journal-title":"Biomolecules"},{"issue":"1","key":"3647_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"WY Zhou","year":"2020","unstructured":"Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ, Xu RH. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172. https:\/\/doi.org\/10.1186\/s12943-020-01286-3.","journal-title":"Mol Cancer"},{"issue":"3","key":"3647_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","volume":"71","author":"X Li","year":"2018","unstructured":"Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71(3):428\u201342. https:\/\/doi.org\/10.1016\/j.molcel.2018.06.034.","journal-title":"Mol Cell"},{"issue":"1","key":"3647_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-023-00386-0","volume":"20","author":"Y Fu","year":"2023","unstructured":"Fu Y, Jia Q, Ren M, et al. Circular RNA ZBTB46 depletion alleviates the progression of atherosclerosis by regulating the ubiquitination and degradation of hnRNPA2B1 via the AKT\/mTOR pathway. Immun Ageing. 2023;20(1):66. https:\/\/doi.org\/10.1186\/s12979-023-00386-0.","journal-title":"Immun Ageing"},{"issue":"1","key":"3647_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-025-01306-x","volume":"27","author":"S Greco","year":"2025","unstructured":"Greco S, Gaetano C, Mazzaccaro D, Martelli F. Circular RNA role in atherosclerosis development and progression. Curr Atheroscler Rep. 2025;27(1):60. https:\/\/doi.org\/10.1007\/s11883-025-01306-x.","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"3647_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00927-1","volume":"30","author":"J Ju","year":"2023","unstructured":"Ju J, Li XM, Zhao XM, et al. Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia\/reperfusion injury by interacting with NAMPT. J Biomed Sci. 2023;30(1):45. https:\/\/doi.org\/10.1186\/s12929-023-00927-1.","journal-title":"J Biomed Sci"},{"issue":"16","key":"3647_CR19","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1093\/cvr\/cvad161","volume":"119","author":"L Wang","year":"2023","unstructured":"Wang L, Feng J, Feng X, et al. Exercise-induced circular RNA circUtrn is required for cardiac physiological hypertrophy and prevents myocardial ischaemia-reperfusion injury. Cardiovasc Res. 2023;119(16):2638\u201352. https:\/\/doi.org\/10.1093\/cvr\/cvad161.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"3647_CR20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02341-2020","volume":"57","author":"C Guignabert","year":"2021","unstructured":"Guignabert C, Humbert M. Targeting transforming growth factor-\u03b2 receptors in pulmonary hypertension. Eur Respir J. 2021;57(2):2002341. https:\/\/doi.org\/10.1183\/13993003.02341-2020.","journal-title":"Eur Respir J"},{"issue":"2","key":"3647_CR21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01830-2024","volume":"66","author":"O Sitbon","year":"2025","unstructured":"Sitbon O, Boucly A, Weatherald J, et al. Drugs targeting novel pathways in pulmonary arterial hypertension. Eur Respir J. 2025;66(2):2401830. https:\/\/doi.org\/10.1183\/13993003.01830-2024.","journal-title":"Eur Respir J"},{"issue":"16","key":"3647_CR22","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s00018-017-2510-4","volume":"74","author":"M Orriols","year":"2017","unstructured":"Orriols M, Gomez-Puerto MC, Ten Dijke P. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension. Cell Mol Life Sci. 2017;74(16):2979\u201395. https:\/\/doi.org\/10.1007\/s00018-017-2510-4.","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"3647_CR23","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1016\/j.cell.2025.03.001","volume":"188","author":"AMK Rothman","year":"2025","unstructured":"Rothman AMK, Florentin A, Zink F, et al. Therapeutic potential of allosteric HECT E3 ligase inhibition. Cell. 2025;188(10):2603-2620.e18. https:\/\/doi.org\/10.1016\/j.cell.2025.03.001.","journal-title":"Cell"},{"issue":"9","key":"3647_CR24","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.121.319971","volume":"130","author":"O Boucherat","year":"2022","unstructured":"Boucherat O, Agrawal V, Lawrie A, Bonnet S. The latest in animal models of pulmonary hypertension and right ventricular failure. Circ Res. 2022;130(9):1466\u201386. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319971.","journal-title":"Circ Res"},{"issue":"2","key":"3647_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.semcancer.2019.12.023","volume":"67","author":"L Fu","year":"2020","unstructured":"Fu L, Cui CP, Zhang X, Zhang L. The functions and regulation of Smurfs in cancers. Semin Cancer Biol. 2020;67(2):102\u201316. https:\/\/doi.org\/10.1016\/j.semcancer.2019.12.023.","journal-title":"Semin Cancer Biol"},{"issue":"1-2","key":"3647_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s1359-6101(99)00025-8","volume":"11","author":"K Miyazono","year":"2000","unstructured":"Miyazono K. TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev. 2000;11(1\u20132):15\u201322. https:\/\/doi.org\/10.1016\/s1359-6101(99)00025-8.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"3647_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100397","volume":"4","author":"Y Li","year":"2022","unstructured":"Li Y, Fan W, Link F, Wang S, Dooley S. Transforming growth factor \u03b2 latency: a mechanism of cytokine storage and signalling regulation in liver homeostasis and disease. JHEP Rep. 2022;4(2):100397. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100397.","journal-title":"JHEP Rep"},{"issue":"11","key":"3647_CR28","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.7150\/thno.42423","volume":"10","author":"X Chen","year":"2020","unstructured":"Chen X, Li HD, Bu FT, et al. Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p\/FBXW7 axis. Theranostics. 2020;10(11):4851\u201370. https:\/\/doi.org\/10.7150\/thno.42423.","journal-title":"Theranostics"},{"key":"3647_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep40342","volume":"7","author":"CM Tang","year":"2017","unstructured":"Tang CM, Zhang M, Huang L, et al. CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts. Sci Rep. 2017;7:40342. https:\/\/doi.org\/10.1038\/srep40342.","journal-title":"Sci Rep"},{"issue":"42","key":"3647_CR30","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1093\/eurheartj\/ehac337","volume":"43","author":"D Lu","year":"2022","unstructured":"Lu D, Chatterjee S, Xiao K, et al. A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicity. Eur Heart J. 2022;43(42):4496\u2013511. https:\/\/doi.org\/10.1093\/eurheartj\/ehac337.","journal-title":"Eur Heart J"},{"issue":"13","key":"3647_CR31","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/cvr\/cvae148","volume":"120","author":"Z Pan","year":"2024","unstructured":"Pan Z, Lv J, Zhao L, et al. CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages. Cardiovasc Res. 2024;120(13):1531\u201349. https:\/\/doi.org\/10.1093\/cvr\/cvae148.","journal-title":"Cardiovasc Res"},{"key":"3647_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.atherosclerosis.2019.05.006","volume":"286","author":"L Wang","year":"2019","unstructured":"Wang L, Shen C, Wang Y, et al. Identification of circular RNA Hsa_circ_0001879 and Hsa_circ_0004104 as novel biomarkers for coronary artery disease. Atherosclerosis. 2019;286:88\u201396. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.05.006.","journal-title":"Atherosclerosis"},{"issue":"11","key":"3647_CR33","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1016\/j.ymthe.2022.06.016","volume":"30","author":"H Zheng","year":"2022","unstructured":"Zheng H, Huang S, Wei G, et al. CircRNA Samd4 induces cardiac repair after myocardial infarction by blocking mitochondria-derived ROS output. Mol Ther. 2022;30(11):3477\u201398. https:\/\/doi.org\/10.1016\/j.ymthe.2022.06.016.","journal-title":"Mol Ther"},{"issue":"3","key":"3647_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.299","volume":"4","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Boeckel JN, Yao J, et al. Diagnosis of acute myocardial infarction using a combination of circulating circular RNA cZNF292 and clinical information based on machine learning. MedComm. 2023;4(3):e299. https:\/\/doi.org\/10.1002\/mco2.299.","journal-title":"MedComm"},{"issue":"3","key":"3647_CR35","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.ymthe.2020.12.004","volume":"29","author":"N Wu","year":"2021","unstructured":"Wu N, Xu J, Du WW, et al. YAP Circular RNA, circYap, Attenuates Cardiac Fibrosis via Binding with Tropomyosin-4 and Gamma-Actin Decreasing Actin Polymerization. Mol Ther. 2021;29(3):1138\u201350. https:\/\/doi.org\/10.1016\/j.ymthe.2020.12.004.","journal-title":"Mol Ther"},{"key":"3647_CR36","doi-asserted-by":"publisher","DOI":"10.34133\/research.0451","volume":"7","author":"TK Shan","year":"2024","unstructured":"Shan TK, Yang TT, Jing P, et al. Circular RNA IGF1R Promotes Cardiac Repair via Activating \u03b2-Catenin Signaling by Interacting with DDX5 in Mice after Ischemic Insults. Research. 2024;7:0451. https:\/\/doi.org\/10.34133\/research.0451.","journal-title":"Research"},{"issue":"2","key":"3647_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.123.066430","volume":"150","author":"H Shen","year":"2024","unstructured":"Shen H, Gao Y, Ge D, et al. BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension. Circulation. 2024;150(2):132\u201350. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.066430.","journal-title":"Circulation"},{"issue":"7","key":"3647_CR38","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1172\/JCI83361","volume":"126","author":"AMK Rothman","year":"2016","unstructured":"Rothman AMK, Arnold ND, Pickworth JA, et al. MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension. J Clin Invest. 2016;126(7):2495\u2013508. https:\/\/doi.org\/10.1172\/JCI83361.","journal-title":"J Clin Invest"},{"issue":"1","key":"3647_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01444-7","volume":"21","author":"H Le Ribeuz","year":"2020","unstructured":"Le Ribeuz H, Courboulin A, Ghigna MR, et al. In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression. Respir Res. 2020;21(1):186. https:\/\/doi.org\/10.1186\/s12931-020-01444-7.","journal-title":"Respir Res"},{"issue":"11","key":"3647_CR40","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1093\/cvr\/cvaa350","volume":"117","author":"BJ Dunmore","year":"2021","unstructured":"Dunmore BJ, Jones RJ, Toshner MR, Upton PD, Morrell NW. Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus. Cardiovasc Res. 2021;117(11):2309\u201325. https:\/\/doi.org\/10.1093\/cvr\/cvaa350.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3647_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/genes12010008","volume":"12","author":"S Dannewitz Prosseda","year":"2020","unstructured":"Dannewitz Prosseda S, Ali MK, Spiekerkoetter E. Novel advances in modifying BMPR2 signaling in PAH. Genes. 2020;12(1):8. https:\/\/doi.org\/10.3390\/genes12010008.","journal-title":"Genes"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03647-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03647-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03647-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:09:43Z","timestamp":1782972583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03647-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3647"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03647-w","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: the affiliation was updated.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments conformed to the Guide for the Care and Use of Laboratory Animals [National Institutes of Health (NIH), Bethesda, MD, USA], and were authorized by the Animal Ethics Committee of The Affiliated Nanjing Hospital of Nanjing Medical University (Approval document number: DWSY-25126759; Date of approval: 14th July 2025).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}